Сorneal crosslinking in children with keratoconus. Literature review
https://doi.org/10.21516/2072-0076-2025-18-4-164-168
Abstract
The article presents a review of the literature data on the results of corneal crosslinking (CXL) for the treatment of keratoconus (KC) in pediatric patients. There are many reports on the results of corneal CXL in children with KC, but most studies were conducted in small cohort groups, have a short follow-up period, and there are conflicting opinions on the effectiveness of different protocols for this procedure. The use of this procedure in the treatment of pediatric KC stops or slows down its progression according to the results of all studies. Due to the rapid progression of KC in childhood, some authors suggest the use of corneal CXL even in the absence of documentary evidence of disease progression. The development of the most optimal corneal CXL protocol with high efficiency and safety for children of different age groups remains an important problem, which requires further research.
About the Authors
G. Kh. ZainutdinovaRussian Federation
Guzel K. Zainutdinova — Dr. of Med. Sci., senior researcher of the scientific and educational department
90 Pushkin St., Ufa, 450008
G. M. Kazakbaeva
Russian Federation
Gyulli M. Kazakbaeva — Cand. of Med. Sci., head of the department of ophthalmological and medical epidemiology
90 Pushkin St., Ufa, 450008
A. V. Insapova
Russian Federation
Anastasia V. Insapova — researcher, department of ophthalmological and medical epidemiology
90 Pushkin St., Ufa, 450008
D. A. Timerbulatova
Russian Federation
Diana A. Timerbulatova — researcher, department of ophthalmological and medical epidemiology
90 Pushkin St., Ufa, 450008
R. I. Bagmanov
Russian Federation
Radmir I. Bagmanov — ophthalmologist, 1st microsurgical department
90 Pushkin St., Ufa, 450008
References
1. Vohra V, Tuteja S, Gurnani B, Chawla H. Collagen Cross linking for keratoconus. 2023 Jun 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
2. Prasher P, Sharma A, Sharma R, Vig VK., Nirankari VS. Paediatric cornea crosslinking current strategies: A review. Advances in Ophthalmology Practice and Research. 2023; 3,2: 55–62. doi: 10.1016/j.aopr.2022.11.002
3. Xu L, Wang YX, Guo Y, et al. Prevalence and associations of steep cornea/ keratoconus in greater Beijing. The Beijing Eye Study. PLoS One. 2012; 7(7): e39313. doi: 10.1371/journal.pone.0039313
4. Shehadeh MM, Diakonis VF, Jalil SA, et al. Prevalence of keratoconus among a palestinian tertiary student population. Open Ophthalmol J. 2015; (9): 172–6. doi: 10.2174/1874364101509010172
5. Godefrooij DA, de Wit GA, Uiterwaal CS, et al. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. Am J Ophthalmol. 2017; 175: 169–2. doi: 10.1016/j.ajo.2016.12.015
6. Bikbov M.M., Bikbova G.M. Corneal ectasia. Moscow: “Oftalmologiya”. 2011 (In Russ.).
7. Khalimov А.Р., Surkova В.К., Kazakbaeva G.М. The structure and function of the cornea. Literature Review. Point of View. East — West. 2022; 1: 45–50 (In Russ.). https://east-west-journal.ru/index.php/east-west/article/view/32
8. Tur VM, MacGregor C, Jayaswal R, et al. A review of keratoconus: Diagnosis, pathophysiology, and genetics. Surv Ophthalmol. 2017; 62 (6): 770–83. doi: 10.1016/j.survophthal.2017.06.009
9. Wisse RP, Kuiper JJ, Gans R, et al. Cytokine expression in keratoconus and its corneal microenvironment: a systematic review. Ocul Surf. 2015; 13 (4): 272–83. doi: 10.1016/j.jtos.2015.04.006
10. Singh RBr, Koh S, Sharma N, et al. Keratoconus. Nat Rev Dis Primers. 2024; 10 (1): 81. doi: 10.1038/s41572-024-00565-3
11. Chatzis N, Hafezi F. Progression of keratoconus and efficacy of corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012; 28 (11): 753–8. doi: 10.3928/1081597X-20121011-01
12. McAnena L, Doyle F, O’Keefe M. Cross-linking in children with keratoconus: a systematic review and meta-analysis. Acta Ophthalmol. 2017; 95 (3): 229–39. doi: 10.1111/aos.13224
13. Polido J, Araújo ME, Dos XS, Alexander JG, et al. Pediatric Crosslinking: Current Protocols and Approach. Ophthalmol. Ther. 2022; 11: 983–99. doi: 10.1007/s40123-022-00508-9
14. Chang CY, Hersh PS. Corneal collagen cross-linking. Eye Contact Lens. 2014; 40 (6): 345–52. doi: 10.1097/ICL.0000000000000094
15. Léoni-Mesplié S, Mortemousque B, Touboul D, et al. Scalability and severity of keratoconus in children. Am J Ophthalmol. 2012; 154: 6–62.e1. doi: 10.1016/j.ajo.2012.01.025
16. Ahuja P, Dadachanji Z, Shetty R, et al. Relevance of IgE, allergy and eye rubbing in the pathogenesis and management of Keratoconus. Indian J Ophthalmol. 2020; 68: 2067–74. doi: 10.4103/ijo.IJO_1191_19
17. Galvis V, Tello A, Carreño NI, Berrospi RD, Niño CA. Risk factors for keratoconus: Atopy and eye rubbing. Cornea. 2017; 36: e1. doi: 10.1097/ICO.0000000000001052
18. Peyman A, Namgar M, Feizi A, Ganjalikhani M. Interleukin-6 and tumor necrosis factor-α levels in tear film of Keratoconus patients. Journal of Research in Medical Sciences. 2021; 26 (1): 75. doi: 10.4103/jrms.jrms_35_21
19. Balasubramanian SA, Mohan S, Pye DC, Willcox MD. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol. 2012; 90: e303–9. doi: 10.1111/j.1755-3768.2011.02369.x
20. Macsai M, Maguen E, Nucci P. Keratoconus and Turners syndrome. Cornea.1997; 16 (5): 534–6.
21. Ren S, Yang K, Xu L, et al. Machine learning analysis with the comprehensive index of corneal tomographic and biomechanical parameters in detecting pediatric subclinical keratoconus. Front Bioeng Biotechnol. 2023; 11: 1273500. doi: 10.3389/fbioe.2023.1273500
22. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135: 620–7. doi:10.1016/s0002-9394(02)02220-1
23. Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit cornea after photodynamic collagen crosslinking. Acta Ophthalmol. 2009 Feb; 87 (1): 48–51. doi: 10.1111/j.1755-3768.2008.01190.x
24. O’Brart DPS, Chan E, Samaras K, et al. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol. 2011; 95: 1519–24. doi:10.1136/bjo.2010.196493
25. Wittig-Silva C, Chan E, Islam FMA, et al. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus. Ophthalmology. 2014; 121: 812–21. doi: 10.1016/j.ophtha.2013.10.028
26. Galvis V, Tello A, Ortiz AI, Escaf LC. Patient selection for corneal collagen cross-linking: an updated review. Clin Ophthalmol. 2017; 11: 657–68. doi: 10.2147/OPTH.S101386
27. Surkova В., Khalimov А., & Kazakbaeva Г. Keratectasias and modern methods of their treatment. Point of View. East — West. 2022; 2: 84–8 (In Russ.). https://east-west-journal.ru/index.php/east-west/article/view/116
28. Hersh P, Greenstein S, Fry K. Corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. Journal of Cataract and Refractive Surgery. 2011; 37 (1): 149–60. doi: 10.1016/j.jcrs.2010.07.030
29. Gomes JA, Tan D, Rapuano CJ, et al. Group of Panelists for the Global Delphi Panel of Keratoconus and Ectatic Diseases. Global consensus on keratoconus and ectatic diseases. Cornea. 2015; 34 (4): 359–69. doi: 10.1097/ICO.0000000000000408
30. Hafezi F. Limitation of collagen crosslinking with hypo-osmolar riboflavin solution: failure in extremely thin corneas. Cornea. 2011; 30 (8): 917–9. doi: 10.1097/ICO.0b013e31820143d1
31. Koç M, Uzel M, Koban Y, et al. Accelerated corneal crosslinking with hypoosmolar riboflavin solution in keratoconus thin corneas: short-term results. Cornea. 2016; 35 (3): 350–4. doi: 10.1097/ICO.000000000000000701
32. Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea. 2009; 28 (4): 474–6. doi: 10.1097/ICO.0b013e31818d381a
33. Sharma N, Maharana P, Singh G, Tritiya JS. Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. J Cataract Refract Surg. 2010; 36 (3): 517–20. doi: 10.1016/j.jcrs.2009.08.041
34. Al-Qarni A, AlHarbi M. Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-a for keratoconus. East Afr J Ophthalmol. 2015; 22 (3): 389–92. doi: 10.4103/0974-9233.159777
35. Yuksel N, Bilgihan K, Hondur AM. Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-A for progressive keratoconus. Int Ophthalmol. 2011; 31 (6): 513–5. doi: 10.1007/s10792-011-9489-x
36. Ferrari G, Iuliano L, Viganò M, Rama P. Impending corneal perforation after collagen cross-linking for herpetic keratitis. J Cataract Refract Surg. 2013; 39 (4): 638–41. doi: 10.1016/j.jcrs.2013.02.006
37. Sitaula S, Singh SK, Gurung A. Bilateral viral keratitis following corneal collagen crosslinking for progressive keratoconus. J Ophthalmic Inflamm Infect. 2019; 9 (1): 16. doi: 10.1186/s12348-019-0185-8
38. Wang L, Deng Y, Ma K, et al. Herpetic keratitis following corneal crosslinking for keratoconus: A case series. Infect Drug Resist. 2022; 15: 6555–62. doi: 10.2147/IDR.S389920
39. Steinwender G, Pertl L, El-Shabrawi Y, et al. Complications from corneal cross-linking for keratoconus in pediatric patients. J Refract Surg. 2016; 32 (1): 68–9. doi: 10.3928/1081597X-20151210-03
40. Maharana PK, Sahay P, Sujeeth M, et al. Microbial keratitis after accelerated corneal collagen cross-linking in keratoconus. Cornea. 2018; 37 (2): 162–7. doi: 10.1097/ICO.0000000000001439
41. Arora R, Simalandhi P, Goyal JL, Gupta D. Results of corneal collagen cross-linking in pediatric patients. J Refract Surg. 2012; 11: 759–62. doi: 10.3928/1081597X-20121011-02
42. Padmanabhan P, Reddi SR, Rajagopal R, et al. Corneal collagen cross-linking for keratoconus in pediatric patients — long term results. Cornea. 2017; 36 (2): 138–3. doi: 10.1097/ICO.0000000000001102
43. Zotta PG, Diakonis VF, Kymionis GD, et al. Long-term outcomes of corneal cross-linking for keratoconus in pediatricpatients. J AAPOS. 2017; 21 (5): 397–401. doi: 10.1016/j.jaapos.2017.07.205
44. Mazzotta C, Traversi C, Baiocchi S, et al. Corneal collagen crosslinking with riboflavin and ultraviolet a light for pediatric keratoconus: ten-year results. Cornea. 2018; 37 (5): 560–6. doi: 10.1097/ICO.0000000000001505
45. Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012; 28 (11): 753–8. doi: 10.3928/1081597X-20121011-01
46. Vinciguerra P, Albé E, Frueh BE, et al. Two-year results of corneal crosslinking in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol. 2012;154:520–6. doi: 10.1016/j.ajo.2012.03.020.
47. Godefrooij DA, Soeters N, Imhof SM, et al. Corneal crosslinking in childhood keratoconus: long-term results. Cornea. 2016; 35: 954–8. doi: 10.1097/ICO.00000000000000819
48. Bikbov M.M., Zainutdinova G.C., Usubov E.L., Lukianova E.E., Oganisyan K.C. Results of treatment of keratectasia by the corneal cross-linking method in children and teenagers. Fyodorov journal of ophthalmic surgery. 2015; (3): 43–6 (In Russ.).
49. Padmanabhan P, Reddi SR, Rajagopal R, et al. Corneal collagen cross-linking for keratoconus in pediatric patients-long-term results. Cornea. 2017; 36 (2): 138–3. doi: 10.1097/ICO.0000000000001102
50. Chowdhury K, Dore C, Burr JM, et al. A randomised, controlled, observermasked trial of corneal cross-linking for progressive keratoconus in children: the KERALINK protocol. BMJ Open. 2019 Sep 12; 9 (9): e028761. doi: 10.1136/bmjopen-2018-028761
51. Larkin DFP, Chowdhury K, Burr JM, et al. KERALINK Trial Study Group. Effect of corneal cross-linking versus standard care on keratoconus progression in young patients: The KERALINK randomized controlled trial. Ophthalmology. 2021; 128 (11): 1516–6. doi: 10.1016/j.ophtha.2021.04.019
52. Nicula CA, Rednik AM, Bulboacă AE, et al. Comparative results between “Epi-Off” conventional and accelerated corneal collagen crosslinking for progressive keratoconus in pediatric patients. Therapeut Clin Risk Manag. 2019; 15: 1483–90. doi: 10.2147/TCRM.S224533
53. Nath S, Shen C, Koziarz A, et al. Transepithelial versus epithelium-off corneal collagen cross-linking for corneal ectasia: a systematic review and meta-analysis. Ophthalmology. 2021; 128 (8): 1150–60. doi: 10.1016/j.ophtha.2020.12.023
54. Bikbov M.M., Surkova V.K., Bikbova G.M., Zainullina N.B. Сlinical results of transepithelial corneal collagen crosslinking in patients with keratoconus. Ophthalmology in Russia. 2016; 13 (1): 4–9 (In Russ.). https://doi.org/10.18008/1816-5095-2016-1-4-9
55. Singh T, Taneja M, Murthy S, et al. Evaluation of safety and efficacy of different protocols of collagen cross linking for keratoconus. Rom J Ophthalmol. 2020 Apr-Jun; 64 (2): 158–67. PMID: 32685782.
56. Markova E.Yu., Avakyants G.V., Kechin E.V. Keratoconus in children. Мodern treatment options.current trends in the treatment of keratoconus in children. Оphthalmology in Russia. 2021; 18 (4): 840–4 (In Russ.). doi: 10.18008/1816-5095-2021-4-840-844
57. Eissa SA, Yassin A. Prospective, randomized contralateral eye study of accelerated and conventional corneal cross-linking in pediatric keratoconus. Int Ophthalmol. 2019; 39 (5): 971–9. doi: 10.1007/s10792-018-0898-y
58. Oliverio GW, Vagge A, Gargano R, Aragona P, Roszkowska AM. Clinical results of accelerated iontophoresis-assisted epithelium-on corneal cross-linking for progressive keratoconus in children. J Pediatr Ophthalmol Strabismus. 2024; 61 (1): 44–50. doi: 10.3928/01913913-20230421-01
59. Buzzonetti L, Petrocelli G, Valente P, et al. Iontophoretic transepithelial collagen cross-linking versus epithelium-off collagen cross-linking in pediatric patients: 3-year follow-up. Cornea. 2019; 38 (7): 859–63. doi: 10.1097/ICO.0000000000001965
60. Henriquez MA, Rodríguez AM, Izquierdo LJr. Accelerated epi-on versus standard epi-off corneal collagen cross-linking for progressive keratoconus in pediatric patients. Cornea. 2017; 36 (12): 1503–8. doi: 10.1097/ICO.0000000000001366
61. Iqbal M, Elmassry A, Saad H, et al. Standard cross-linking protocol versus accelerated and transepithelial cross-linking protocols for treatment of paediatric keratoconus: A 2-year comparative study. Acta Ophthalmol. 2020; 98: e352–e362. doi: 10.1111/aos.14275
62. Henriquez MA, Hernandez-Sahagun G, Camargo J, Izquierdo JrL. Accelerated epi-on versus standard epi-off corneal collagen cross-linking for progressive keratoconus in pediatric patients: Five years of follow-up. Cornea. 2020; 39 (12): 1493–8. doi: 10.1097/ICO.0000000000002463
63. Sarac O, Caglayan M, Uysal BS, Uzel AGT, Tanriverdi B, Cagil N. Accelerated versus standard corneal collagen cross-linking in pediatric keratoconus patients: 24 months follow-up results. Cont Lens Anterior Eye. 2018; 41 (5): 442–7. doi: 10.1016/j.clae.2018.06.001
64. Saleh S, Koo EB, Lambert SR, Manche EE. Outcomes after corneal crosslinking for keratoconus in children and young adults. Cornea. 2022; 41 (4): 408–16. doi: 10.1097/ICO.0000000000002730
65. Kobashi H, Hieda O, Itoi M, et al. The Keratoconus Study Group of Japan. Corneal cross-linking for paediatric keratoconus: A systematic review and meta-analysis. J Clin Med. 2021; 10 (12): 2626. doi: 10.3390/jcm10122626
66. Cehelyk EK, Syed ZA. Long-term outcomes of corneal crosslinking. Current Opinion in Ophthalmology. 2024; 35 (4): 315–21. doi: 10.1097/ICU.0000000000001054
Review
For citations:
Zainutdinova G.Kh., Kazakbaeva G.M., Insapova A.V., Timerbulatova D.A., Bagmanov R.I. Сorneal crosslinking in children with keratoconus. Literature review. Russian Ophthalmological Journal. 2025;18(4):164-168. (In Russ.) https://doi.org/10.21516/2072-0076-2025-18-4-164-168


























